Drug
Obeticholic Acid (OCA)
Obeticholic Acid (OCA) is a pharmaceutical drug with 5 clinical trials. Historical success rate of 60.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
60.0%
Based on 3 completed trials
Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
167%(5 trials)
Terminated
2(40%)
Phase Distribution
Ph phase_3
1
20%
Ph phase_2
2
40%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
60.0%
3 of 5 finished
Non-Completion Rate
40.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(3)
Terminated(2)
Detailed Status
Completed3
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
60.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
Trials by Status
terminated240%
completed360%
Recent Activity
0 active trials
Showing 5 of 5
terminatedphase_4
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
NCT02308111
terminatedphase_4
Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment
NCT03633227
completedphase_2
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
NCT02177136
completedphase_2
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
NCT00570765
completedphase_3
Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
NCT01473524
Clinical Trials (5)
Showing 5 of 5 trials
NCT02308111Phase 4
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
NCT03633227Phase 4
Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment
NCT02177136Phase 2
Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC)
NCT00570765Phase 2
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
NCT01473524Phase 3
Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5